Clearance Summary
ARCHIECT INSULIN AND CONTROLS, MODEL 8K41-01, 8K41-10 received FDA 510(k) clearance under submission number K060359, sponsored by Denka Seiken Co., Ltd.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2006-04-14.
- Submission: K060359
- Applicant / Sponsor: Denka Seiken Co., Ltd.
- Clearance pathway: Abbreviated
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1150
- Decision date: 2006-04-14
Classification & Regulation
This clearance is catalogued under FDA product code JIT and 21 CFR 862.1150, within the Clinical Chemistry review panel as a Class II device.